ABHD6: Difference between revisions
CSV import |
CSV import |
||
| Line 26: | Line 26: | ||
{{medicine-stub}} | {{medicine-stub}} | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Latest revision as of 03:43, 17 March 2025
ABHD6 (Alpha/Beta Hydrolase Domain Containing 6) is a protein that in humans is encoded by the ABHD6 gene. This protein is part of the serine hydrolase family of enzymes, which are involved in a variety of biological processes, including lipid metabolism and inflammation.
Function[edit]
ABHD6 is a lipase that is primarily located in the mitochondria of cells. It plays a crucial role in the regulation of endocannabinoid signaling pathways by controlling the levels of 2-arachidonoylglycerol (2-AG), a major endocannabinoid. By hydrolyzing 2-AG, ABHD6 helps to regulate the duration and intensity of endocannabinoid signaling.
Clinical Significance[edit]
Research has suggested that ABHD6 may be a potential therapeutic target for the treatment of obesity and related metabolic disorders. Inhibition of ABHD6 has been shown to increase levels of 2-AG, which can enhance insulin sensitivity and reduce inflammation. However, further research is needed to fully understand the potential therapeutic applications of targeting ABHD6.
See Also[edit]
References[edit]
<references />

